Jon Montgomery
About Jon Montgomery
Jon M. Montgomery, age 74, is an independent director and Chairperson of the Board at Nuvve Holding Corp. (NVVE), serving on the Board since November 2020; he was Interim Chair beginning January 2024 and is listed as Chairperson in 2025 filings . He holds an MBA from Northeastern University and a BA from the University of California, Berkeley, and has extensive experience in project finance, marketing analytics, and board governance .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| AGlobal Partners LLC | Managing Partner (project finance advisory) | 2010–2013 | Arranged limited-recourse financing across renewables, telecom, mining; advised on FDI using DFIs, ECAs, political risk insurers |
| Meredith Financial Group Inc. | Managing Director | (current) | Financial management and advisory services |
| Hudson Group Inc. | Co-founder, marketing consultancy | 1996–2010 | Led quantitative, choice-based modeling for competitive strategy across IT, telecom, financials, CPG, pharma, retail |
| Marketing Strategy & Planning Inc./Synovate | EVP | (prior to 1996) | Strategy and planning leadership |
| Hase Schannen Research Associates Inc. | VP | (prior to 1996) | Market research leadership |
External Roles
| Organization | Role | Since | Committees/Notes |
|---|---|---|---|
| Nature’s Miracle Holding Corp. (Nasdaq: NMHI) | Director | Mar 2024 | Chair, Nominating & Governance; Member, Audit and Compensation |
| University of Georgia | Adjunct Faculty (Marketing) | 2000–2022 | Academic contribution in marketing |
| Meredith Financial Group Inc. | Managing Director | Current | Financial advisory |
Board Governance
- Board classification: Class A (term expiring 2025); Montgomery was nominated for re-election at the Aug 22, 2025 annual meeting .
- Current role: Chairperson of the Board; structure separates CEO and Chair roles, with independent director executive sessions held regularly without management .
- Independence: Board determined Montgomery qualifies as an independent director under Nasdaq rules .
- Committee assignments: Chair of Nominating & Corporate Governance; Member of Audit and Compensation (Compensation Committee chaired by H. David Sherman) .
- Attendance: In FY2024 the Board met 19 times; all directors attended at least 75% of Board and committee meetings .
Fixed Compensation
| Director Compensation Program (Cash) | Amount (USD) |
|---|---|
| Annual Director Cash Retainer | $40,000 |
| Additional Annual Compensation for Chairperson of the Board | $70,000 |
| Committee Chair – Audit | $20,000 |
| Committee Chair – Compensation | $15,000 |
| Committee Chair – Nominating & Governance | $10,000 |
| Committee Member – Audit | $10,000 |
| Committee Member – Compensation | $7,500 |
| Committee Member – Nominating & Governance | $5,000 |
| Director | Year | Cash Fees (USD) | Stock Awards (USD) | Total (USD) |
|---|---|---|---|---|
| Jon M. Montgomery | 2024 | $67,500 | $0 | $67,500 |
Notes:
- The program sets the cash structure; actual fees reflect role and timing (e.g., interim chair in 2024) .
Performance Compensation
| Director | Year | Equity Award Type | Grant Date | Shares/Units | Grant Date Fair Value (USD) |
|---|---|---|---|---|---|
| Jon M. Montgomery | 2024 | — | — | — | $0 (no stock awards disclosed) |
- NVVE’s Amended & Restated 2020 Equity Incentive Plan authorizes options, SARs, RSUs and restricted stock for eligible participants (including directors), with evergreen and change-of-control provisions; non-employee director annual awards capped at lesser of 400,000 shares or $400,000 by grant date fair value .
Other Directorships & Interlocks
| Company | Industry Relationship to NVVE | Potential Interlock/Conflict |
|---|---|---|
| Nature’s Miracle Holding Corp. (NMHI) | Hydroponics/agritech; no disclosed supplier/customer overlap with NVVE | None disclosed; committee roles at NMHI |
- No related-party transactions disclosed involving Montgomery; Audit Committee reviews and must approve any related-party transactions under policy and charter .
Expertise & Qualifications
- Project finance and structuring expertise across infrastructure and renewables; advised on financing using DFIs/ECAs and political risk insurance .
- Quantitative marketing and choice-based modeling expertise; decades of market research leadership .
- Academic engagement (Adjunct, University of Georgia) and governance experience; current NMHI committee chair roles .
Equity Ownership
| Snapshot Date | Shares Beneficially Owned | % of Shares Outstanding | Notes |
|---|---|---|---|
| June 25, 2025 | 446 | * (less than 1%) | Based on 10,613,022 shares outstanding |
| Sept 4, 2025 | 100,446 | * (less than 1%) | Based on 20,252,314 shares outstanding |
- No options/warrants positions disclosed for Montgomery in the outstanding director options table for 2024 .
- No pledging or hedging disclosures specific to Montgomery; NVVE has an insider trading policy and code of ethics governing such conduct .
Governance Assessment
- Independence and multi-committee participation (Audit, Compensation, Nominating & Governance chair) are positives for board effectiveness; executive sessions reinforce oversight .
- Attendance exceeded 75% alongside a high Board meeting cadence (19 in FY2024), indicating engagement .
- Compensation structure emphasizes cash retainers; no director stock awards disclosed for Montgomery in 2024, limiting equity alignment signals that some investors prefer in micro-cap turnarounds .
- Audit Committee oversight of related-party transactions is pertinent given insider financings (CEO/CFO notes and warrants); Montgomery’s Audit Committee role is central to mitigating conflicts, with formal policies and indemnification in place .
- Broader governance environment includes repeated reverse stock split authorizations to address Nasdaq minimum bid price compliance; Montgomery signed as Chair for the 2025 special meeting advocating these measures—necessary for listing compliance but indicative of continued capital structure stress that investors should monitor .
- Clawback policy compliant with Nasdaq rules is in place, supporting pay-for-performance and risk mitigation; Compensation Committee retains sole authority to hire independent consultants .